Eucrates Biomedical Acquisition Corp. announced the pricing of its $100 million IPO this morning and its units are expected to begin trading on the Nasdaq under the symbol “EUCRU” today, Friday, October 23.
The new company aims to combine with a North American or European healthcare target with the potential to drive transformational change through the convergence of biomedicine and data science. Eucrates is led by Chairman Dr. Stelios Papadopoulos, CEO and Director Parag Saxena, President COO and Director Dr. Evangelos Vergetis, and CFO Gonzalo Gordova.
Total SPAC deal count for 2020 year-to-date is now 160 with $58.99 billion in gross proceeds raised. This offering is expected to close on Tuesday, October 27.
Stifel, Nicolaus & Company, Inc. and H.C. Wainwright & Co. LLC are acting as joint book-running managers for the offering. Proskauer Rose LLP is serving as Issuer’s Counsel with Kirkland & Ellis LLP serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company LLC is acting as trustee.
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...
Trump Media (NASDAQ:DJT) is down about -15% in the pre-market following the filing of its first S-1 since closing its combination with Digital World, and this includes the issuance of the 21,491,251 shares. Of these, 14,375,000 are to be made available for those exercising warrants while the rest would go out to note holders from...
At the SPAC of Dawn This week, bookended by the end of Ramadan and the beginning of Passover, could wind up stacked with events to avoid those holiday times, but for now SPACs have scheduled just six extension votes for this stretch. Redwood (NASDAQ:RWOD) and Genesis Growth Tech (OTC:GGAAF) have yet to release results from...